Author: admin1271

Retreatment with Hyaluronic Acid Viscosupplementation in Knee Osteoarthritis: Agreement between EUROVISCO Guidelines and Current Medical Practice

Posted on by admin1271

Retreatment with Hyaluronic Acid Viscosupplementation in Knee Osteoarthritis: Agreement between EUROVISCO Guidelines and Current Medical Practice Yves Henrotin 1, Cedric Tits 2, Jérôme Paul 2, Pierre Gramme 2, Thibault Helleputte 2, Alberto Migliore 3, Pascal Richette 4, Xavier Chevalier 5, Jordi Monfort 6, Demirhan Diracoglu 7, Hervé Bard 8, Jörg Jerosch 9, Dominique Baron 10, Read more about Retreatment with Hyaluronic Acid Viscosupplementation in Knee Osteoarthritis: Agreement between EUROVISCO Guidelines and Current Medical Practice[…]

Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO group

Posted on by admin1271

Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO group Thierry Conrozier 1 , Raghu Raman 2 , Xavier Chevalier 3 , Yves Henrotin 4 , Jordi Monfort 5 , Demirhan Diraçoglù 6 , Hervé Bard 7 , Dominique Baron 8 , Jörg Jerosch 9 , Pascal Richette 10 , Alberto Migliore 11 >>> Read more about Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO group[…]

The EUROVISCO Group at Antalya Camp Inject International in November 2018

Posted on by admin1271

Last year, some of the Eurovisco members attended the Antalya Camp Inject International 2018 and presented the work done so far by the Group. As you can see in these pictures, our team of experts, Pr Demirhan Dıraçoğlu, Dr Ragh Raman and Pr Migliore all participated actively to the Turkish congress. Here below, the presentation displayed Read more about The EUROVISCO Group at Antalya Camp Inject International in November 2018[…]

EUROVISCO Guidelines for the Design and Conduct of Clinical Trials Assessing the Disease-Modifying Effect of Knee Viscosupplementation

Posted on by admin1271

EUROVISCO Guidelines for the Design and Conduct of Clinical Trials Assessing the Disease-Modifying Effect of Knee Viscosupplementation Yves Henrotin 1 , Xavier Chevalier 2 , Raghu Raman 3 , Pascal Richette 4 , Jordi Montfort 5 , Jörg Jerosch 6 , Dominique Baron 7 , Hervé Bard 8 , Yannick Carrillon 9 , Alberto Migliore Read more about EUROVISCO Guidelines for the Design and Conduct of Clinical Trials Assessing the Disease-Modifying Effect of Knee Viscosupplementation[…]

EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in Osteoarthritis

Posted on by admin1271

EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in Osteoarthritis Thierry Conrozier, Jordi Monfort, Xavier Chevalier, Raghu Raman, Pascal Richette, Demirhan Diraçoglù, Hervé Bard, Dominique Baron, Jörg Jerosch, Alberto Migliore, and Yves Henrotin, >>> Online Abstract <<< Abstract Objectives The 3 aims of the work were to identify population subgroups that can benefit the Read more about EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in Osteoarthritis[…]

Eurovisco at the ISIAT Congress in Prague in October 2017

Posted on by admin1271

The 4th edition of the International Symposium on Intra-Articular Treatment (ISIAT) took place in Prague last 5th to 7th of October 2017. Organized every two years across different European cities by Prof. Alberto Migliore (IT), this congress is, as its name suggests, focus on intra-articular management of joint disease including intra-articular access, therapeutic targets and Read more about Eurovisco at the ISIAT Congress in Prague in October 2017[…]

Eurovisco at the OARSI Congress in Las Vegas in April 2017

Posted on by admin1271

Eurovisco participated at the OARSI 2017 World Congress which took place from the 27th to the 30th of April 2017 in Las Vegas. The scientific work of the group related to retreatment with viscosupplementation has been presented in a poster during this congress. Re-treatment with viscosupplementation in patients with knee OA: suggestions of the EUROSVICO Read more about Eurovisco at the OARSI Congress in Las Vegas in April 2017[…]

Retreatment with Viscosupplementation in Knee OA

Posted on by admin1271

Retreatment with Viscosupplementation in Knee OA: Discover the 2nd paper of the EUROVISCO Group Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering from Knee Osteoarthritis. Recommendations from the EUROpean VIScosupplementation COnsensus Group (EUROVISCO). R. Raman, Y. Henrotin, X. Chevalier, A. Migliore, J. Jerosch, J. Montfort, H. Bard, D. Baron, P. Richette, T. Conrozier. Read more about Retreatment with Viscosupplementation in Knee OA[…]

Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering from Knee Ostheoarthritis: Recommendations from the European Viscosupplémentation Consensus Group (EUROVISCO)

Posted on by admin1271

Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering from Knee Osteoarthritis: Recommendations from the EUROpean VIScosupplementation COnsensus Group (EUROVISCO) Raghu Raman 1 , Yves Henrotin 2 , Xavier Chevalier 3 , Alberto Migliore 4 , Jörg Jerosch 5 , Jordi Montfort 6 , Hervé Bard 7 , Dominique Baron 8 , Pascal Richette Read more about Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering from Knee Ostheoarthritis: Recommendations from the European Viscosupplémentation Consensus Group (EUROVISCO)[…]

Eurovisco attended the 3rd Edition of the ISIAT Congress in Budapest on 1-3 October 2015

Posted on by admin1271

Eurovisco attended the 3rd International Symposium on Intra-Articular Treatment (ISIAT) Congress which took place in Budapest on 1-3 October 2015. The following oral communication was presented by Dr. Thierry Conrozier: Consensus statement on hyaluronic acid intra-articular injections for the management of osteoarthritis. T. Conrozier, Y. Henrotin, P. Richette, H. Bard, J. Jerosch, X. Chevalier, R. Read more about Eurovisco attended the 3rd Edition of the ISIAT Congress in Budapest on 1-3 October 2015[…]